Legal & General Group PLC Mirum Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 167,230 shares of MIRM stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,230

Previous 43,010 288.82%

Holding current value

$11.9 Million

Previous $2.19 Million 460.28%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$48.39 - $77.69 $6.01 Million - $9.65 Million	124,220 Added 288.82%	167,230 $12.3 Million
Q2 2025 Aug 12, 2025	BUY	$38.39 - $51.11 $6,756 - $8,995	176 Added 0.41%	43,010 $2.19 Million
Q1 2025 May 15, 2025	BUY	$41.32 - $53.16 $83,218 - $107,064	2,014 Added 4.93%	42,834 $1.93 Million
Q4 2024 Feb 13, 2025	BUY	$37.85 - $46.65 $52,573 - $64,796	1,389 Added 3.52%	40,820 $1.69 Million
Q3 2024 Feb 28, 2025	SELL	$33.68 - $44.74 $155,668 - $206,788	-4,622 Reduced 11.32%	36,198 $1.41 Million

Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $67,797 - $90,061	2,013 Added 5.38%	39,431 $1.54 Million
Q2 2024 May 29, 2025	BUY	$23.57 - $34.85 $130,577 - $193,069	5,540 Added 19.34%	34,185 $1.17 Million
Q2 2024 Aug 14, 2024	BUY	$23.57 - $34.85 $206,779 - $305,739	8,773 Added 30.63%	37,418 $1.28 Million
Q1 2024 May 29, 2025	SELL	$24.92 - $30.02 $353,589 - $425,953	-14,189 Reduced 33.13%	28,645 $719,000
Q1 2024 Jul 01, 2024	BUY	$24.92 - $30.02 $33,542 - $40,406	1,346 Added 4.93%	28,645 $719,000
Q1 2024 May 14, 2024	SELL	$24.92 - $30.02 $34,937 - $42,088	-1,402 Reduced 4.88%	27,299 $685,000
Q4 2023 May 29, 2025	SELL	$27.14 - $34.93 $383,569 - $493,665	-14,133 Reduced 32.99%	28,701 $847,000
Q4 2023 Feb 15, 2024	BUY	$27.14 - $34.93 $164,386 - $211,571	6,057 Added 26.75%	28,701 $847,000
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $45,171 - $60,246	1,834 Added 8.81%	22,644 $715,000
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $306,358 - $392,102	13,031 Added 167.52%	20,810 $538,000
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $9,556 - $12,001	498 Added 6.84%	7,779 $186,000
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $13,946 - $20,549	698 Added 10.6%	7,281 $153,000
Q2 2022 Aug 22, 2022	BUY	$18.42 - $27.5 $115,972 - $173,140	6,296 Added 2193.73%	6,583 $128,000
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $906 - $1,311	-65 Reduced 18.47%	287 $6,000
Q2 2021 Aug 12, 2021	SELL	$15.84 - $20.6 $2,249 - $2,925	-142 Reduced 28.74%	352 $6,000
Q3 2020 Nov 13, 2020	SELL	$18.4 - $26.59 $5,961 - $8,615	-324 Reduced 39.61%	494 $9,000
Q1 2020 May 14, 2020	BUY	$9.38 - $23.79 $2,504 - $6,351	267 Added 48.46%	818 $11,000
Q4 2019 Feb 13, 2020	BUY	$6.84 - $25.9 $3,768 - $14,270	551 New	551 $14,000

Others Institutions Holding MIRM

# of Institutions

290

Shares Held

57.5M

Call Options Held

86.1K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.63B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Mirum Pharmaceuticals, Inc. Transaction History